Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PARSACLISIB for Follicular lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where PARSACLISIB was used for Follicular lymphoma.

Most Reported Side Effects for PARSACLISIB

Side Effect Reports % Deaths Hosp.
Off label use 23 31.1% 1 8
Disease progression 15 20.3% 1 1
Pyrexia 14 18.9% 0 10
Pneumonia 11 14.9% 0 9
Bronchitis 9 12.2% 0 9
Neutropenic sepsis 9 12.2% 0 9
Neutrophil count decreased 9 12.2% 0 9
Blood lactate dehydrogenase increased 8 10.8% 0 1
Neutropenia 8 10.8% 1 2
Hypokalaemia 7 9.5% 0 7
Enterococcal bacteraemia 6 8.1% 0 0
Intentional product use issue 6 8.1% 0 6
Thrombocytopenia 6 8.1% 0 0
Acute kidney injury 5 6.8% 1 4
Alanine aminotransferase increased 5 6.8% 1 0

Other Indications for PARSACLISIB

Diffuse large b-cell lymphoma (24) Mantle cell lymphoma (11) B-cell lymphoma (6) Product used for unknown indication (5)

Other Drugs Used for Follicular lymphoma

LENALIDOMIDE (3,611) RITUXIMAB (3,294) OBINUTUZUMAB (2,527) BENDAMUSTINE (1,560) CYCLOPHOSPHAMIDE (1,367) VINCRISTINE (1,224) DOXORUBICIN (1,115) PREDNISONE (889) TAZEMETOSTAT HYDROBROMIDE (439) ETOPOSIDE (352)

Related Pages

PARSACLISIB Full Profile All Follicular lymphoma Drugs PARSACLISIB Demographics PARSACLISIB Timeline